Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lyra Therapeutics (LYRA) Amortizatization of Intangibles (2023 - 2024)

Historic Amortizatization of Intangibles for Lyra Therapeutics (LYRA) over the last 2 years, with Q4 2024 value amounting to $267000.0.

  • Lyra Therapeutics' Amortizatization of Intangibles fell 7545.96% to $267000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $2.3 million, marking a year-over-year decrease of 3489.7%. This contributed to the annual value of $2.3 million for FY2024, which is 3489.7% down from last year.
  • According to the latest figures from Q4 2024, Lyra Therapeutics' Amortizatization of Intangibles is $267000.0, which was down 7545.96% from $401000.0 recorded in Q3 2024.
  • Lyra Therapeutics' 5-year Amortizatization of Intangibles high stood at $1.1 million for Q4 2023, and its period low was $267000.0 during Q4 2024.